Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B | $9.70B | $6.82B | $5.74B | $5.46B | $5.10B | $4.87B | $4.33B |
| Research & development | — | — | — | — | — | — | — | — | — | — | $3.3M | $5.8M | $5.0M | $10.4M | $10.0M |
| Operating income | $2.18B | $2.20B | $1.98B | $1.80B | $1.39B | $731.0M | $777.0M | $741.0M | $665.0M | $576.0M | $646.0M | $590.0M | $462.3M | $396.4M | $345.3M |
| EBITDAderived | $3.33B | $3.32B | $3.10B | $2.93B | $2.66B | $2.02B | $1.98B | $1.88B | $1.68B | $865.0M | $774.0M | $711.0M | $569.8M | $494.7M | $437.3M |
| Net income | $1.36B | $1.37B | $1.36B | $1.09B | $966.0M | $279.0M | $191.0M | $259.0M | $1.28B | $72.0M | $387.0M | $357.0M | $226.6M | $177.5M | $241.8M |
| Basic EPSper diluted share | $7.91 | $7.57 | $7.39 | $5.82 | $5.05 | $1.46 | $0.98 | $1.27 | $5.86 | $0.48 | $3.15 | $2.78 | $1.83 | $1.53 | $2.08 |
| Diluted EPSper diluted share | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 | $5.74 | $0.47 | $3.08 | $2.72 | $1.77 | $1.51 | $2.05 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 18, 2025Form 4 | BOUSBIB ARISee Remarks | SellCommon Stock | 36.6K | $222.43 | $8.13M | 820.6K |
| Oct 29, 2025Form 4 | Sherbet EricSee Remarks | SellCommon Stock | 4.0K | $219.70 | $878.8K | 27.1K |
| Oct 29, 2025Form 4 | BOUSBIB ARISee Remarks | SellCommon Stock | 4.0K | $221.97 | $881.9K | 828.2K |
| Oct 29, 2025Form 4 | BOUSBIB ARISee Remarks | SellCommon Stock | 26.1K | $221.31 | $5.78M | 832.2K |
| Oct 29, 2025Form 4 | BOUSBIB ARISee Remarks | SellCommon Stock | 4.6K | $220.11 | $1.01M | 858.3K |